None listed
Conditions
Brief summary
to test the feasibility, safety, and efficacy of contraceptive devices fitting during elective cesarean delivery as well as the impact of this intervention on peurperal and menstrual blood loss.
Interventions
There are a total of three groups in this study (a) Copper containing intra-uterine contraceptive device (IUCD) inserted during cesarean section (C.S.) for future contraception, (b) Levonorgestrel containing device inserted for the same indication and (c) Cesarean section without device insertion. Copper containing contraceptive device is the standard IUD used for birth control while Levonorgestrel containing intra-uterine system (IUS) is a newer intrauterine contraceptive device with a steroid reservoir that releases 20 micrograms of levonorgestrel daily. Insertion during cesarean section, requires one minute to perform to be removed on patient request or after expiry of the device (5 years for levonorgestrel device, and 10 years for IUCD), however the duration of follow-up in the study is only 18 months.
Sponsors
Study design
Eligibility
Inclusion criteria
healthy women, with full-term pregnancy, undergoing elective cesarean delivery, with no medical problems, normal uterus.
Exclusion criteria
labor pains, multiple pregnancy, medical problems, uterine pathology.